Mountain Group Partners (“MGP”) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences, AgTech and Technology sectors. Founded in 2002, MGP principals have invested in more than 50 companies in these sectors.
MGP invests in seed and early stage companies. Within Life Sciences, the fund focuses on Medical Devices, Diagnostics, and Opportunistic Drug Development. Our firm places a premium on those innovations that have existing intellectual property or a novel scientific foundation for building intellectual property. AgTech investments focus on disruptive technologies that have a meaningful impact on global animal health and agriculture. Technology investments focus on Business and Healthcare Technology, targeting those ideas with quantifiable development risk and a rapid path to market.